<DOC>
	<DOC>NCT01373801</DOC>
	<brief_summary>The objective of the study is to assess the safety and efficacy of the HemCon GuardaCareXR compared to standard bandaging in subjects with post partum hemorrhage as a result of cervical and vaginal lacerations. The primary endpoint will be a cessation of bleeding at 30 minutes after insertion of the dressing.</brief_summary>
	<brief_title>Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Lacerations</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<criteria>1. Signed Informed Consent 2. Age≥18 year 3. Two or more 2nd degree vaginal lacerations , 3rd degree vaginal lacerations and cervical laceration 1. Subjects undertaking anticoagulation treatment 2. Preexisting coagulopathy 3. Massive uncontrolled bleeding requiring blood transfusions/urgent vascular surgery. 4. Systolic blood pressure &lt;90mmHg 5. Shellfish allergy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Postpartum women, after surgical repair of vaginal and cervical lacerations</keyword>
</DOC>